#VisualAbstract: Oral azacitidine did not improve progres-sion-free survival but had a better safety profile for follicular helper T-cell lymphoma
Click here to read this study in The Lancet.
©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.
